For the first time in more than 30 years, stimulant drugs — cocaine and methamphetamine — now kill more Americans annually than opioids. That statistic, buried in a 14 April 2026 NPR analysis of preliminary CDC mortality data, is a measure of how dramatically the opioid death toll has fallen: not because stimulant deaths have risen, but because fentanyl deaths have plunged fast enough to restructure the entire overdose picture.
Preliminary data from the Centers for Disease Control and Prevention projects 71,542 drug overdose deaths for the 12 months ending October 2025 — a 17.1 percent decline from the same period a year earlier. If confirmed in final statistics, that drop would represent the sharpest single-year reduction in overdose deaths since the CDC began tracking them systematically. The previous record was a 7 percent decline in 2018 — itself brief, reversed within 18 months as fentanyl analogue proliferation undid the gains.
Researchers have identified a cluster of contributing factors. Less potent fentanyl appearing in illicit markets in certain states, expanded access to buprenorphine and naloxone, higher community saturation of harm-reduction programmes, and measurable declines in drug use among people under 25 all appear in the emerging literature. In Maine — a state that has been a bellwether for opioid mortality trends since 2016 — no person under the age of 25 died from a drug overdose in the 12 months ending February 2026, according to the Maine Office of Behavioral Health.
“Researchers have identified a cluster of contributing factors.”
